JSW
AMED

Journey Strategic Wealth’s Amedisys AMED Stock Holding History

Journey Strategic Wealth’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,398
Closed -$236K – 709
2025
Q2 		$236K Buy
+2,398
New +$227K 0.01% 535

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Journey Strategic Wealth's AMED Position: Q3 2025 in Review

Journey Strategic Wealth sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,398 shares — an estimated $236K sold.

Journey Strategic Wealth first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $236K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Journey Strategic Wealth reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Journey Strategic Wealth sold 2,398 Amedisys shares in Q3 2025, an estimated $236K.
  • Journey Strategic Wealth first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Journey Strategic Wealth's Amedisys position peaked at $236K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Journey Strategic Wealth's 13F filing for Q3 2025, filed 12 Nov 2025.